Evidence map›Paper›PMID 31480481›Full record

ArticleInternational journal of molecular sciences2019

Oral Administration of Microencapsulated

Nancy Valadez-Bustos, Eleazar M Escamilla-Silva, Francisco J García-Vázquez, Marco A Gallegos-Corona, Silvia L Amaya-Llano, Minerva Ramos-Gómez

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Frontiers in microbiology · 2024
    Article
  6. Article
  7. The Effect of Dietary Factors on Cancer.International journal of molecular sciences · 2023
    Article
  8. Review
  9. RecombinantFrontiers in microbiology · 2022
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nancy Valadez-BustosGraduate Studies in Food Science, School of Chemistry, Autonomous University of Queretaro, Cerro de las Campanas S/N, C.P. 76010, Querétaro, Mexico.
Eleazar M Escamilla-SilvaChemical Engineering Department, National Technological of Mexico, Tecnológico y Antonio García Cubas S/N C.P. 38010, Guanajuato, Mexico.
Francisco J García-VázquezMolecular Immunogenetics Laboratory, National Institute of Pediatrics, Insurgentes Sur 3700-C, Cuicuilco, C.P. 04530, Ciudad de México, Mexico.
Marco A Gallegos-CoronaHistoptology Laboratory, School of Medicine, Autonomous University of Queretaro. Clavel 200, Prados de la Capilla, C.P. 76017, Querétaro, Mexico.
Silvia L Amaya-LlanoGraduate Studies in Food Science, School of Chemistry, Autonomous University of Queretaro, Cerro de las Campanas S/N, C.P. 76010, Querétaro, Mexico.
Minerva Ramos-GómezGraduate Studies in Food Science, School of Chemistry, Autonomous University of Queretaro, Cerro de las Campanas S/N, C.P. 76010, Querétaro, Mexico. minervaramos9297@gmail.com.
Autonomous University of Queretaro · MXTecnológico Nacional de México · MXUniversidad Insurgentes · MX

Funding

Tecnológico Nacional de México 6656.18-PUniversidad Autónoma de Querétaro 1299
6 · The paper itself

Abstract

The Insulin-like growth factor-I/Insulin-like growth factor-I receptor (IGF-1/IGF-1R) system is a major determinant in colorectal cancer (CRC) pathogenesis. Probiotics (

Indexed as

Bifidobacterium longumAdministration, OralAnimalsAnticarcinogenic AgentsColorectal NeoplasmsDisease Models, AnimalInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor ILycopeneMaleMiceMice, Inbred ICRProbioticsReceptor, IGF Type 1Anticarcinogenic AgentsInsulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor ILycopeneReceptor, IGF Type 1B. longum microencapsulatedcolorectal cancergastrointestinal bacterial distributionIGF-1/IGF-1R/IGFBPs systemlycopene

Identifiers

PMID31480481
PMCPMC6747182
OpenAlexW2970143782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.